IBRX Securities Fraud Lawsuit: Investor Deadline Approaching
ImmunityBio, Inc. investors who purchased securities during the January-March 2026 period face a critical deadline to participate in an ongoing securities fraud lawsuit. The Rosen Law Firm is actively seeking lead plaintiffs to represent the investor class in this significant case.
IBRX Securities Fraud Lawsuit: Investor Deadline Approaching Read More »








